EUCTR2020-004487-25-SE进行中（未招募）1 期
Experiencing the self through touch - self-other-distinction in an altered state of self: An exploratory randomized placebo-controlled experimental medicine study
inköpings Universitet0 个研究点目标入组 30 人开始时间: 2020年9月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Age 18-65 years, and willing to provide informed consent.
- •2.Good health as determined by medical history, ECG, and clinical assessment of lab tests. Lab tests will include potassium, creatinine, hemoglobin, glucose, calcium, BUN, complete blood count, total bilirubin, TSH, AST, ALT, and GGT. The final decision will be according to the judgment of the lead physician.
- •3.Proficiency in Swedish.
- •4.Fertile females must have a negative urine pregnancy test (hCG) at inclusion and at the start of each study session. Females of childbearing potential who are sexually active and have not been surgically sterilized must agree to use an adequate method of birth control during the study.
- •5.Participant must be willing to receive two i.v. lines and undergo an MRI scan.
- •6.Participant must be willing to perform the touch task including self-touch and receiving touch from the investigator on the arm.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Any clinically significant medical condition, including CNS, cardiovascular, respiratory, gastrointestinal, hepatic, renal, endocrine, or reproductive disorders, as assessed by the Principal Investigator (PI) or designee, after appropriate consults if needed.
- •2.Known hypersensitivity to ketamine, eclampsia, pre-eclampsia, increased intraocular pressure, hyperthyroidism, hydrocephalus, hypertension.
- •3.Any current clinically significant psychiatric problems including a diagnosis of substance dependence other than nicotine (defined in DSM-5 terms as Substance Use Disorder, Moderate or Severe as assessed by PI or designee. Patients will be screened using the Modified Mini Screen (MMS), the Drug Use Disorder Identification Test (DUDIT), a urine drug screening, and the Alcohol Use Disorder Identification Test (AUDIT). The results and their clinical significance will ultimately be evaluated by a trained healthcare professional (psychiatrically trained nurse or physician). If indication is obtained that a clinically significant psychiatric disorder may be present, a full MINI interview will be carried out by appropriately trained staff.
- •4.Any medical condition that, in the judgment of the PI or designee and after appropriate consultation if needed, is likely to influence cerebral blood flow or gross-level brain activity/anatomy, such as for instance: type-1 diabetes, cardiovascular or respiratory disease, history of significant head injury, hyper-/hypothyroidism, epilepsy.
- •5.History of psychotic experiences and familial history (first and second degree relatives) of psychosis or alcohol use disorder.
- •6.Any use of CNS-active medications, use of prescription or over-the-counter drugs that could interfere with the ketamine administration. This includes Theophylline, Suxametonium, Atracurium, Diazepam, Vasopressin, barbiturates, Ergometrine, sympathomimetics, narcotics and sedatives, inhalation anesthetics, muscular relaxants, thyroid hormones, antihypertensive agents, CYP3A4 inhibitors ((e g itraconazole, fluconazole, clarithromycin, erythromycin, verapamil, diltiazem) and CYP3A4 inducers (e.g. phenytoin, carbamazepine, St John´s Wort).
- •7.Unable to provide a negative urine drug screen (including amphetamine, THC, opiates and benzodiazepines).
- •8.Pregnancy, intention to become pregnant, or breastfeeding.
- •9.Contraindications for magnetic resonance imaging (MRI) scanning, including ferromagnetic objects in the body that are contraindicated for MRI, and claustrophobia.
- •10.Any other condition due to which, in the judgment of the PI or designee, participation in the study is not in the subject’s best interest, or is unlikely to yield valid data.
研究者
相似试验
尚未招募
不适用
The sense of touch: embodied simulation processes and empathy in Autism Spectrum Disordersautism spectrum disorders1005716710037176autismNL-OMON30908Katholieke Universiteit Nijmegen40
尚未招募
不适用
Discovering the sense of touch- somatosensory discrimination training for children with cerebral palsyCerebral palsyHemiplegiaImpaired tactile discriminationImpaired haptic object recognitionImpaired limb positionACTRN12618000348257Perth Children's Hospital50
已完成
不适用
Somatic experience as a new technology for the treatment of posttraumatic stress trauma.Post-Traumatic Stress DisordersF03.950.750.500F04.096.670RBR-4pk67hHospital Universitário Lauro Wanderley/UFPB
招募中
不适用
Studies Into Touch in Healthy Humans to Provide Sensory Feedback in ProsthesesSomatosensory DisordersAmputationTactile DisordersAgingProsthesis UserNCT05548322Institut National de la Santé Et de la Recherche Médicale, France210
尚未招募
2 期
Affective touch processing in skin-picking disorder698.4 - DSM 5 - Skin Picking DisorderDRKS00022123niversität Graz120